Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase

MeSH terms

• Anemia, Hemolytic / chemically induced*
• Anemia, Hemolytic / drug therapy
• Anemia, Hemolytic / therapy
• Antioxidants / therapeutic use
• Ascorbic Acid / therapeutic use
• Cyclophosphamide / adverse effects
• Cyclophosphamide / therapeutic use
• Glucosephosphate Dehydrogenase Deficiency / complications*
• Hemolysis / drug effects
• Humans
• Male
• Methemoglobinemia / chemically induced*
• Methemoglobinemia / drug therapy
• Methemoglobinemia / therapy
• Middle Aged
• Multiple Myeloma / blood
• Multiple Myeloma / complications*
• Multiple Myeloma / drug therapy
• Myeloablative Agonists / adverse effects
• Myeloablative Agonists / therapeutic use
• Treatment Outcome
• Tumor Lysis Syndrome / prevention & control*
• Urate Oxidase / adverse effects*
• Urate Oxidase / therapeutic use